Chapter Contents
Chapter Contents
Previous
Previous
Next
Next
The NPAR1WAY Procedure

Getting Started

This example illustrates how you can use PROC NPAR1WAY to perform a one-way nonparametric analysis. The data* consist of weight gain measurements for five different levels of gossypol additive. Gossypol is a substance contained in cottonseed shells, and these data were collected to study the effect of gossypol on animal nutrition.

The following DATA step statements create the SAS data set Gossypol:

   data Gossypol;
      input Dose n;
      do i=1 to n;
         input Gain @@;
         output;
      end;
      datalines;
    0 16
      228 229 218 216 224 208 235 229 233 219 224 220 232 200 208 232

   .04 11
      186 229 220 208 228 198 222 273 216 198 213
   .07 12
      179 193 183 180 143 204 114 188 178 134 208 196
   .10 17
      130 87 135 116 118 165 151 59 126 64 78 94 150 160 122 110 178
   .13 11
      154 130 130 118 118 104 112 134 98 100 104
   ;

The data set Gossypol contains the variable Dose, which represents the amount of gossypol additive, and the variable Gain, which represents the weight gain.

Researchers are interested in whether there is a difference in weight gain among the different dose levels of gossypol. The following statements invoke the NPAR1WAY procedure to perform a nonparametric analysis of this problem.

   proc npar1way data=Gossypol;
      class Dose;
      var Gain;
   run;

The variable Dose is the CLASS variable, and the VAR statement specifies the variable Gain is the response variable. The CLASS statement is required, and you must name only one CLASS variable. You may name one or more analysis variables in the VAR statement. If you omit the VAR statement, PROC NPAR1WAY analyzes all numeric variables in the data set except for the CLASS variable, the FREQ variable, and the BY variables.

Since no analysis options are specified in the PROC NPAR1WAY statement, the WILCOXON, MEDIAN, VW, SAVAGE, and EDF options are invoked by default. The results of these analyses are shown in the following tables.

The NPAR1WAY Procedure

Analysis of Variance for
Variable Gain
Classified by Variable
Dose
Dose N Mean
0 16 222.187500
0.04 11 217.363636
0.07 12 175.000000
0.1 17 120.176471
0.13 11 118.363636

Source DF Sum of Squares Mean Square F Value Pr > F
Among 4 140082.986077 35020.74652 55.8143 <.0001
Within 62 38901.998997 627.45160    
Average scores were used for ties.

These tables are produced with the ANOVA option. For each level of the CLASS variable Dose, PROC NPAR1WAY displays the number of observations and the mean of the analysis variable Gain. PROC NPAR1WAY displays a standard analysis of variance on the raw data. This gives the same results as the GLM and ANOVA procedures. The p-value for the F test is <.0001, which indicates that Dose accounts for a significant portion of the variability in the dependent variable Gain.

The NPAR1WAY Procedure

Wilcoxon Scores (Rank Sums) for Variable Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 890.50 544.0 67.978966 55.656250
0.04 11 555.00 374.0 59.063588 50.454545
0.07 12 395.50 408.0 61.136622 32.958333
0.1 17 275.50 578.0 69.380741 16.205882
0.13 11 161.50 374.0 59.063588 14.681818
Average scores were used for ties.

Kruskal-Wallis Test
Chi-Square 52.6656
DF 4
Pr > Chi-Square <.0001


The WILCOXON option produces these tables. PROC NPAR1WAY first provides a summary of the Wilcoxon scores for the analysis variable Gain by class level. For each level of the CLASS variable Dose, PROC NPAR1WAY displays the following information: number of observations, sum of the Wilcoxon scores, expected sum under the null hypothesis of no difference among class levels, standard deviation under the null hypothesis, and mean score.

Next PROC NPAR1WAY displays the one-way ANOVA statistic, which for Wilcoxon scores is known as the Kruskal-Wallis test. The statistic equals 52.6656, with four degrees of freedom, which is the number of class levels minus one. The p-value, or probability of a larger statistic under the null hypothesis, is <.0001. This leads to rejection of the null hypothesis that there is no difference in location for Gain among the levels of Dose. This p-value is asymptotic, computed from the asymptotic chi-square distribution of the test statistic. For certain data sets it may also be useful to compute the exact p-value; for example, for small data sets, or data sets that are sparse, skewed, or heavily tied. You can use the EXACT statement to request exact p-values for any of the location or scale tests available in PROC NPAR1WAY.

The NPAR1WAY Procedure

Median Scores (Number of Points Above Median) for Variable
Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 16.0 7.880597 1.757902 1.00
0.04 11 11.0 5.417910 1.527355 1.00
0.07 12 6.0 5.910448 1.580963 0.50
0.1 17 0.0 8.373134 1.794152 0.00
0.13 11 0.0 5.417910 1.527355 0.00
Average scores were used for ties.

Median One-Way Analysis
Chi-Square 54.1765
DF 4
Pr > Chi-Square <.0001


The NPAR1WAY Procedure

Van der Waerden Scores (Normal) for Variable Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 16.116474 0.0 3.325957 1.007280
0.04 11 8.340899 0.0 2.889761 0.758264
0.07 12 -0.576674 0.0 2.991186 -0.048056
0.1 17 -14.688921 0.0 3.394540 -0.864054
0.13 11 -9.191777 0.0 2.889761 -0.835616
Average scores were used for ties.

Van der Waerden One-Way Analysis
Chi-Square 47.2972
DF 4
Pr > Chi-Square <.0001


The NPAR1WAY Procedure

Savage Scores (Exponential) for Variable Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 16.074391 0.0 3.385275 1.004649
0.04 11 7.693099 0.0 2.941300 0.699373
0.07 12 -3.584958 0.0 3.044534 -0.298746
0.1 17 -11.979488 0.0 3.455082 -0.704676
0.13 11 -8.203044 0.0 2.941300 -0.745731
Average scores were used for ties.

Savage One-Way Analysis
Chi-Square 39.4908
DF 4
Pr > Chi-Square <.0001


These tables display the analyses produced by the MEDIAN, VW, and SAVAGE options. For each score type, PROC NPAR1WAY provides a summary of scores and the one-way ANOVA statistic, as previously described for Wilcoxon scores. Other score types available in PROC NPAR1WAY are Siegel-Tukey, Ansari-Bradley, Klotz, and Mood, which are used to test for scale differences. Additionally, you can request the SCORES=DATA option, which uses the raw data as scores. This option gives you the flexibility to construct any scores for your data with the DATA step and then analyze these scores with PROC NPAR1WAY.

The NPAR1WAY Procedure

Kolmogorov-Smirnov Test for Variable
Gain
Classified by Variable Dose
Dose N EDF at
Maximum
Deviation from
Mean
at Maximum
0 16 0.000000 -1.910448
0.04 11 0.000000 -1.584060
0.07 12 0.333333 -0.499796
0.1 17 1.000000 2.153861
0.13 11 1.000000 1.732565
Total 67 0.477612  
Maximum Deviation Occurred at Observation 36
Value of Gain at Maximum = 178.0

Kolmogorov-Smirnov Statistics
(Asymptotic)
KS 0.457928 KSa 3.748300

Cramer-von Mises Test for
Variable Gain
Classified by Variable
Dose
Dose N Summed Deviation
from Mean
0 16 2.165210
0.04 11 0.918280
0.07 12 0.348227
0.1 17 1.497542
0.13 11 1.335745

Cramer-von Mises Statistics
(Asymptotic)
CM 0.093508 CMa 6.265003


These tables display the empirical distribution function statistics, comparing the distribution of Gain for the different levels of Dose. These tables are produced by the EDF option, and they include Kolmogorov-Smirnov statistics and Cramer-von Mises statistics.

In the preceding example, the CLASS variable Dose has five levels, and the analyses examines possible differences among these five levels, or samples. The following statements invoke the NPAR1WAY procedure to perform a nonparametric analysis of the two lowest levels of Dose.

   proc npar1way data=Gossypol;
      where Dose <= .04;
      class Dose;
      var Gain;
   run;

The following tables show the results.

The NPAR1WAY Procedure

Analysis of Variance for
Variable Gain
Classified by Variable
Dose
Dose N Mean
0 16 222.187500
0.04 11 217.363636

Source DF Sum of Squares Mean Square F Value Pr > F
Among 1 151.683712 151.683712 0.5587 0.4617
Within 25 6786.982955 271.479318    
Average scores were used for ties.


The NPAR1WAY Procedure

Wilcoxon Scores (Rank Sums) for Variable Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 253.50 224.0 20.221565 15.843750
0.04 11 124.50 154.0 20.221565 11.318182
Average scores were used for ties.

Wilcoxon Two-Sample Test
Statistic 124.5000
   
Normal Approximation  
Z -1.4341
One-Sided Pr < Z 0.0758
Two-Sided Pr > |Z| 0.1515
   
t Approximation  
One-Sided Pr < Z 0.0817
Two-Sided Pr > |Z| 0.1635
Z includes a continuity correction
of 0.5.

Kruskal-Wallis Test
Chi-Square 2.1282
DF 1
Pr > Chi-Square 0.1446


These tables are produced by the WILCOXON option. PROC NPAR1WAY provides a summary of the Wilcoxon scores for the analysis variable Gain for each of the two class levels. Since there are only two levels, PROC NPAR1WAY displays the two-sample test, based on the simple linear rank statistic with Wilcoxon scores. The normal approximation includes a continuity correction. To remove this, you can specify the CORRECT=NO option. PROC NPAR1WAY also gives a t approximation for the Wilcoxon two-sample test. And as for the multisample analysis, PROC NPAR1WAY computes a one-way ANOVA statistic, which for Wilcoxon scores is known as the Kruskal-Wallis test. All these p-values show no difference in Gain for the two Dose levels at the .05 level of significance.

The NPAR1WAY Procedure

Median Scores (Number of Points Above Median) for Variable
Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 9.0 7.703704 1.299995 0.562500
0.04 11 4.0 5.296296 1.299995 0.363636
Average scores were used for ties.

Median Two-Sample Test
Statistic 4.0000
Z -0.9972
One-Sided Pr < Z 0.1593
Two-Sided Pr > |Z| 0.3187

Median One-Way Analysis
Chi-Square 0.9943
DF 1
Pr > Chi-Square 0.3187


The NPAR1WAY Procedure

Van der Waerden Scores (Normal) for Variable Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 3.346520 0.0 2.320336 0.209157
0.04 11 -3.346520 0.0 2.320336 -0.304229
Average scores were used for ties.

Van der Waerden Two-Sample Test
Statistic -3.3465
Z -1.4423
One-Sided Pr < Z 0.0746
Two-Sided Pr > |Z| 0.1492

Van der Waerden One-Way Analysis
Chi-Square 2.0801
DF 1
Pr > Chi-Square 0.1492


The NPAR1WAY Procedure

Savage Scores (Exponential) for Variable Gain
Classified by Variable Dose
Dose N Sum of
Scores
Expected
Under H0
Std Dev
Under H0
Mean
Score
0 16 1.834554 0.0 2.401839 0.114660
0.04 11 -1.834554 0.0 2.401839 -0.166778
Average scores were used for ties.

Savage Two-Sample Test
Statistic -1.8346
Z -0.7638
One-Sided Pr < Z 0.2225
Two-Sided Pr > |Z| 0.4450

Savage One-Way Analysis
Chi-Square 0.5834
DF 1
Pr > Chi-Square 0.4450


These tables display the two-sample analyses produced by the MEDIAN, VW, and SAVAGE options.

The NPAR1WAY Procedure

Kolmogorov-Smirnov Test for Variable
Gain
Classified by Variable Dose
Dose N EDF at
Maximum
Deviation from
Mean
at Maximum
0 16 0.250000 -0.481481
0.04 11 0.545455 0.580689
Total 27 0.370370  
Maximum Deviation Occurred at Observation 4
Value of Gain at Maximum = 216.0

Kolmogorov-Smirnov Two-Sample Test
(Asymptotic)
KS 0.145172 D 0.295455
KSa 0.754337 Pr > KSa 0.6199

Cramer-von Mises Test for
Variable Gain
Classified by Variable
Dose
Dose N Summed Deviation
from Mean
0 16 0.098638
0.04 11 0.143474

Cramer-von Mises Statistics
(Asymptotic)
CM 0.008967 CMa 0.242112

Kuiper Test for Variable
Gain
Classified by Variable
Dose
Dose N Deviation
from Mean
0 16 0.090909
0.04 11 0.295455

Kuiper Two-Sample Test (Asymptotic)
K 0.386364 Ka 0.986440 Pr > Ka 0.8383


These tables display the empirical distribution function statistics, comparing the distribution of Gain for the two levels of Dose. The p-value for the Kolmogorov-Smirnov two-sample test is 0.6199, which indicates no rejection of the null hypothesis that the Gain distributions are identical for the two levels of Dose.

Chapter Contents
Chapter Contents
Previous
Previous
Next
Next
Top
Top

Copyright © 1999 by SAS Institute Inc., Cary, NC, USA. All rights reserved.